CY3

What is Clenbuterol, Liothyronine Sodium, Yohimbine?

CY3 is an oral fat-burning blend containing Clenbuterol (37 mcg/tab), Liothyronine Sodium (T3, 25 mcg/tab), and Yohimbine (5.4 mg/tab) in a 100-tab pack from Dragon Pharma. Designed for cutting cycles, it combines Clenbuterol's beta-2 agonist thermogenesis, T3's thyroid-driven metabolism boost, and Yohimbine's fat mobilization. As an oral medication, it has moderate hepatotoxicity due to T3 and requires careful monitoring due to its stimulant and metabolic effects. It does not aromatize or exhibit anabolic steroid properties.

Mechanism of Action CY3

Clenbuterol stimulates beta-2 receptors, increasing thermogenesis and lipolysis, mobilizing fat stores. Liothyronine Sodium (T3) enhances thyroid hormone activity, boosting metabolic rate by 15-20%, accelerating calorie burn. Yohimbine, an alpha-2 antagonist, enhances fat release from stubborn areas, particularly in low body fat states. Users experience rapid fat loss, increased energy, and enhanced definition within days to weeks.

Half-lives are Clenbuterol (~36-48 hours), T3 (~2.5 days), and Yohimbine (~1-2 hours), requiring daily dosing for optimal effects. The blend doesn't affect androgenic or estrogenic pathways, avoiding hormonal disruptions. What doesn't happen: no significant muscle growth, no water retention, and no HPTA suppression, making it a clean fat-loss tool.

Overuse can cause side effects like jitters or thyroid suppression, manageable with gradual dosing and monitoring.

How It Works & Key Benefits

CY3 excels for bodybuilders in cutting phases with low body fat (under 15%) and a calorie-deficit diet with cardio to maximize its fat-burning potential.

• Promotes rapid fat loss for a shredded physique.
• Preserves lean muscle during aggressive calorie deficits.
• Increases energy and stamina for intense training.
• Targets stubborn fat with synergistic action.
• Enhances metabolic rate for sustained results.
• Stacks well with cutting agents for amplified effects.

Who It's For & Product Specifications

Best for intermediate to advanced bodybuilders and athletes in cutting cycles aiming for rapid fat loss and muscle definition; suitable for men and women with careful dosing. Not recommended for those with cardiovascular issues, thyroid conditions, or without medical clearance.

How to Use

1. Dosage: Start at 1 tab/day (37 mcg Clen, 25 mcg T3, 5.4 mg Yohimbine); increase by 0.5-1 tab every 2-3 days to max 3 tabs/day for men, 2 tabs/day for women.
2. Frequency: Daily, preferably morning to avoid sleep disruption; split doses if needed.
3. Cycle length: 2 weeks on, 2 weeks off for 6-8 weeks to prevent thyroid suppression and receptor downregulation.
4. Preparation/Monitoring tips: Take with water; monitor heart rate, blood pressure, and thyroid function via labs; maintain hydration, electrolytes, and high-protein diet.
5. Results timeline: Fat loss and energy boost in 3-7 days; peak definition in 4-6 weeks.
6. PCT timing: Not required as CY3 doesn't suppress HPTA; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester).

Popular Stacks

Anavar: Enhances fat loss and muscle definition for cutting cycles.

Testosterone Propionate: Preserves muscle during aggressive fat-loss phases.

Clenbuterol: Boosts thermogenesis for intensified results.

Cycle Support: Supports thyroid and cardiovascular health during cycles.

Comparisons & Alternatives

CY3 vs Clenbuterol: CY3 combines T3 and Yohimbine for enhanced fat loss; standalone Clenbuterol is milder with fewer thyroid risks.

CY3 vs T3: CY3 offers synergistic fat burning with Clenbuterol and Yohimbine; standalone T3 is more potent but risks catabolism.

CY3 vs Cagrilintide: CY3 provides rapid thermogenic fat loss; Cagrilintide focuses on appetite suppression for sustained weight loss.

Side Effects & Risk Management

• Cardiometabolic: Jitters, increased heart rate—start low, monitor vitals.
• Endocrine: Thyroid suppression—use short cycles, monitor labs.
• Systemic: Sweating, insomnia—take early, stay hydrated.
• Musculoskeletal: Tremors, cramps—use electrolytes, taurine.
• Hepatic: Moderate strain—monitor liver function.

Review labs with a professional where lawful to ensure authenticity and safe dosing.

Post-Cycle Therapy (PCT)

CY3 requires no PCT as it doesn't suppress HPTA; align with steroid stack's PCT if combined (e.g., 3-4 days post-short ester). Use tamoxifen or clomiphene for 4 weeks if needed, guided by bloodwork.